Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07263230 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety and Efficacy of Roflumilast Foam in HS

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Apr 1, 2026 to Sep 1, 2026 Primary completion pushed from Mar 2028 to Aug 2028 · Completion pushed from Dec 2028 to May 2029v4 Show 2 more changesShow less
    • Primary completion pushed from Mar 2028 to Aug 2028
    • Completion pushed from Dec 2028 to May 2029
  2. Trial status: Not Yet Recruiting to Recruiting Site details revisedv3 Show 1 more changeShow less
    • Site details revised
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates the efficacy of topical roflumilast foam in patients with HS.
Trial Details
NCT Number NCT07263230
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Hidradenitis Suppurativa (HS)
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov